The Peptide AppField Guide · Metabolic SeriesField Specimen

Metabolic Category

Semaglutide

Name: Semaglutide: Uses, Evidence & Safety
Creator: The Peptide App
Published: 2026-01-27T18:38:35.818468+00:00

THE APPETITE CONTROLLER

Ozempic; Wegovy; Rybelsus

Semaglutide is an FDA-approved GLP-1 receptor agonist that has transformed treatment of obesity and type 2 diabetes. It works by mimicking the hormone GLP-1 to reduce appetite, slow stomach emptying, and improve insulin sensitivity. In trials, it produced 15% weight loss and significantly reduced cardiovascular events. Available as weekly injection (Ozempic/Wegovy) or daily oral tablet (Rybelsus).

Semaglutide

Semaglutide Evidence Snapshot

How these guides are reviewed

Regulatory status: FDA-approved uses exist
Dosing guidance: Reviewed by our clinical team
Linked evidence: 1 research sources
Content updated: Aug 28, 2026

Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.

Storage field guide

How long can Semaglutide be out of the fridge?

Check the brand, device, preparation state, and current label before using a day count.

Open storage guide →

Quick Answers About Semaglutide

Is Semaglutide FDA approved?

This profile records Semaglutide as FDA approved.

More context

Approval can be specific to a formulation, indication, and prescribing context, so review the regulatory and source details on this page.

What dose does The Peptide App Clinical Team recommend for Semaglutide?

Dose: Injection: Start 0.25 mg weekly, titrate to 1-2.4 mg weekly.

More context

Oral: Start 3 mg daily, up to 14 mg daily. Schedule: weekly. Cycle: Ongoing as prescribed. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.

What research supports this Semaglutide guide?

This guide links to 1 curated or current research sources.

More context

Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.

Review the Semaglutide research sources

Studied Effects & Mechanisms

Appetite Suppression

Activates hypothalamic POMC neurons to reduce hunger

Insulin Enhancement

Stimulates glucose-dependent insulin secretion

Gastric Slowing

Delays stomach emptying for prolonged fullness

Cardioprotection

Reduces cardiovascular events and inflammation

Who is this for

Those with type 2 diabetes

People with BMI over 30 (obesity)

Those with BMI over 27 with weight-related conditions

Anyone wanting proven, FDA-approved weight loss

Those at high cardiovascular risk

Semaglutide Dosing

Dosage

Injection: Start 0.25 mg weekly, titrate to 1-2.4 mg weekly. Oral: Start 3 mg daily, up to 14 mg daily

Schedule

weekly

Cycle

Ongoing as prescribed

Clinical Team Note

Titrate slowly over months to minimize GI side effects; take oral on empty stomach

Clinical-team guidance calls for titration — start with a lower dose and increase gradually within the appropriate care context.

Get your exact syringe units with the Semaglutide reconstitution calculator

Clinical Team Dosing Guidance

Reported Timeline

Week 1-4

Reduced appetite and food cravings; GI adjustment

Month 1-3

5-7% body weight loss; improved blood sugar

Month 3-6

10-12% body weight loss; metabolic improvements

Month 6-12

15%+ body weight loss; sustained metabolic benefits

Weight loss typically begins within 2-4 weeks; continues for 12+ months.

Timelines summarize reported or expected patterns and are not guaranteed individual outcomes.

Clinical Safety Context

Good Safety

Editorial grade B · Good

SafetyBGood

FDA approval statusApproved uses exist

FDA-approved with well-characterized side effects. GI issues are common but manageable.

Contraindicated in medullary thyroid cancer or MEN 2 syndrome. May cause pancreatitis. Do not mix in the same syringe as other peptides. Inject GLP-1s on their own.

Possible side effects

Nausea · Vomiting · Diarrhea · Constipation · Injection site reactions

How to interpret safety grades

The Peptide App

Set up your Semaglutide schedule

Dose reminders and your schedule, ready the moment you open the app.

Research-Market Price Snapshot

A compact market signal for this profile. The dedicated pricing page owns vendor, vial-size, and price-per-mg comparisons.

Updated Aug 30, 2026

Vendors: 29
Listings: 65
Observed range: $17–$330

Compare all Semaglutide prices →

Market evidence

Semaglutide product testing and COAs

Current certificates are on file for 14 of 32 vendors tracked in the Semaglutide market. Research on this page describes the molecule. Vendor certificates concern particular market samples or batches; they do not change the research evidence or establish clinical safety, sterility, or suitability for use.

View vendor COAs and pricing →Testing database How to read a COA